110 related articles for article (PubMed ID: 31465494)
1. Comparison of knowledge of HIV status and treatment coverage between non-citizens and citizens: Botswana Combination Prevention Project (BCPP).
Marukutira T; Block L; Alwano MG; Behel S; Jarvis JN; Chakalisa U; Powis K; Novitsky V; Bapati W; Wang H; Ussery F; Lebelonyane R; Mills LA; Moore J; Bachanas P
PLoS One; 2019; 14(8):e0221629. PubMed ID: 31465494
[TBL] [Abstract][Full Text] [Related]
2. Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial.
Wirth KE; Gaolathe T; Pretorius Holme M; Mmalane M; Kadima E; Chakalisa U; Manyake K; Matildah Mbikiwa A; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Bennett K; Leidner J; Powis KM; Lebelonyane R; Alwano MG; Jarvis J; Dryden-Peterson SL; Kgathi C; Moore J; Bachanas P; Raizes E; Abrams W; Block L; Sento B; Novitsky V; El-Halabi S; Marukutira T; Mills LA; Sexton C; Pals S; Shapiro RL; Wang R; Lei Q; DeGruttola V; Makhema J; Essex M; Lockman S; Tchetgen Tchetgen EJ
Lancet HIV; 2020 Jun; 7(6):e422-e433. PubMed ID: 32504575
[TBL] [Abstract][Full Text] [Related]
3. To achieve 95-95-95 targets we must reach men and youth: High level of knowledge of HIV status, ART coverage, and viral suppression in the Botswana Combination Prevention Project through universal test and treat approach.
Lebelonyane R; Bachanas P; Block L; Ussery F; Alwano MG; Marukutira T; El Halabi S; Roland M; Abrams W; Ussery G; Miller JA; Lockman S; Gaolathe T; Holme MP; Hader S; Mills LA; Wirth K; Bock N; Moore J
PLoS One; 2021; 16(8):e0255227. PubMed ID: 34375343
[TBL] [Abstract][Full Text] [Related]
4. Increasing knowledge of HIV status in a country with high HIV testing coverage: Results from the Botswana Combination Prevention Project.
Alwano MG; Bachanas P; Block L; Roland M; Sento B; Behel S; Lebelonyane R; Wirth K; Ussery F; Bapati W; Motswere-Chirwa C; Abrams W; Ussery G; Miller JA; Bile E; Fonjungo P; Kgwadu A; Holme MP; Del Castillo L; Gaolathe T; Leme K; Majingo N; Lockman S; Makhema J; Bock N; Moore J
PLoS One; 2019; 14(11):e0225076. PubMed ID: 31765394
[TBL] [Abstract][Full Text] [Related]
5. Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project.
Bachanas P; Alwano MG; Lebelonyane R; Block L; Behel S; Raizes E; Ussery G; Wang H; Ussery F; Pretorius Holme M; Sexton C; Pals S; Lasry A; Del Castillo L; Hader S; Lockman S; Bock N; Moore J
PLoS One; 2021; 16(4):e0250211. PubMed ID: 33882092
[TBL] [Abstract][Full Text] [Related]
6. Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey.
Gaolathe T; Wirth KE; Holme MP; Makhema J; Moyo S; Chakalisa U; Yankinda EK; Lei Q; Mmalane M; Novitsky V; Okui L; van Widenfelt E; Powis KM; Khan N; Bennett K; Bussmann H; Dryden-Peterson S; Lebelonyane R; El-Halabi S; Mills LA; Marukutira T; Wang R; Tchetgen EJ; DeGruttola V; Essex M; Lockman S;
Lancet HIV; 2016 May; 3(5):e221-30. PubMed ID: 27126489
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
[TBL] [Abstract][Full Text] [Related]
9. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
[TBL] [Abstract][Full Text] [Related]
10. Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study.
Lebelonyane R; Bachanas P; Block L; Ussery F; Abrams W; Roland M; Theu J; Kapanda M; Matambo S; Lockman S; Gaolathe T; Makhema J; Moore J; Jarvis JN
Lancet HIV; 2020 Aug; 7(8):e545-e553. PubMed ID: 32763218
[TBL] [Abstract][Full Text] [Related]
11. Male circumcision uptake during the Botswana Combination Prevention Project.
Marukutira T; Ussery F; Kadima E; Mills LA; Moore J; Block L; Bachanas P; Davis S; Schissler T; Mosha R; Komotere O; Diswai T; Ntsuape C; Lebelonyane R; Bock N
PLoS One; 2022; 17(6):e0269178. PubMed ID: 35704556
[TBL] [Abstract][Full Text] [Related]
12. Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana.
Makhema J; Wirth KE; Pretorius Holme M; Gaolathe T; Mmalane M; Kadima E; Chakalisa U; Bennett K; Leidner J; Manyake K; Mbikiwa AM; Simon SV; Letlhogile R; Mukokomani K; van Widenfelt E; Moyo S; Lebelonyane R; Alwano MG; Powis KM; Dryden-Peterson SL; Kgathi C; Novitsky V; Moore J; Bachanas P; Abrams W; Block L; El-Halabi S; Marukutira T; Mills LA; Sexton C; Raizes E; Gaseitsiwe S; Bussmann H; Okui L; John O; Shapiro RL; Pals S; Michael H; Roland M; DeGruttola V; Lei Q; Wang R; Tchetgen Tchetgen E; Essex M; Lockman S
N Engl J Med; 2019 Jul; 381(3):230-242. PubMed ID: 31314967
[TBL] [Abstract][Full Text] [Related]
13. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
[TBL] [Abstract][Full Text] [Related]
14. Achieving the UNAIDS 90-90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa.
Sabapathy K; Balzer L; Larmarange J; Block L; Floyd S; Iwuji C; Wirth K; Ayles H; Fidler S; Kamya M; Petersen M; Havlir D; Dabis F; Moore J; Hayes R
BMC Public Health; 2022 Dec; 22(1):2333. PubMed ID: 36514036
[TBL] [Abstract][Full Text] [Related]
15. HIV Incidence in Botswana Rural Communities With High Antiretroviral Treatment Coverage: Results From the Botswana Combination Prevention Project, 2013-2017.
Ussery F; Bachanas P; Alwano MG; Lebelonyane R; Block L; Wirth K; Ussery G; Sento B; Gaolathe T; Kadima E; Abrams W; Segolodi T; Hader S; Lockman S; Moore J
J Acquir Immune Defic Syndr; 2022 Sep; 91(1):9-16. PubMed ID: 35537094
[TBL] [Abstract][Full Text] [Related]
16. Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana.
Marukutira T; Scott N; Kelly SL; Birungi C; Makhema JM; Crowe S; Stoove M; Hellard M
PLoS One; 2020; 15(1):e0226422. PubMed ID: 31940360
[TBL] [Abstract][Full Text] [Related]
17. A tale of two countries: progress towards UNAIDS 90-90-90 targets in Botswana and Australia.
Marukutira T; Stoové M; Lockman S; Mills LA; Gaolathe T; Lebelonyane R; Jarvis JN; Kelly SL; Wilson DP; Luchters S; Crowe SM; Hellard M
J Int AIDS Soc; 2018 Mar; 21(3):. PubMed ID: 29508945
[TBL] [Abstract][Full Text] [Related]
18. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
19. Health Impact and Cost-Effectiveness of HIV Testing, Linkage, and Early Antiretroviral Treatment in the Botswana Combination Prevention Project.
Resch SC; Foote JHA; Wirth KE; Lasry A; Scott JA; Moore J; Shebl FM; Gaolathe T; Feser MK; Lebelonyane R; Hyle EP; Mmalane MO; Bachanas P; Yu L; Makhema JM; Holme MP; Essex M; Alwano MG; Lockman S; Freedberg KA
J Acquir Immune Defic Syndr; 2022 Aug; 90(4):399-407. PubMed ID: 35420554
[TBL] [Abstract][Full Text] [Related]
20. Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana.
Moyo S; Gaseitsiwe S; Zahralban-Steele M; Maruapula D; Nkhisang T; Mokaleng B; Mohammed T; Ditlhako TR; Bareng OT; Mokgethi TP; van Widenfelt E; Pretorius-Holme M; Mine MO; Raizes E; Yankinda EK; Wirth KE; Gaolathe T; Makhema JM; Lockman S; Essex M; Novitsky V
AIDS; 2019 May; 33(6):1073-1082. PubMed ID: 30946161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
